youtube_live
Q3 2026 earnings
See detailschevron_right
ESL:ETR
EssilorLuxottica SA
€151.50
arrow_downward
-0.59%(-0.90) 1D
Oct 20, 5:30:00 PM GMT+2 · EUR
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ESL...
Open
€153.80
High
€154.55
Low
€151.40
Mkt. cap
75.03B
Avg. vol.
3.25K
Volume
1.94K
P/E ratio
28.28
52-wk high
€323.50
52-wk low
€138.35
EPS
€5.36
No. of employees
214K
Open
€153.80
High
€154.55
Low
€151.40
Mkt. cap
75.03B
Avg. vol.
3.25K
Volume
1.94K
P/E ratio
28.28
52-wk high
€323.50
52-wk low
€138.35
EPS
€5.36
No. of employees
214K
News stories
From web sources and news partners
Quartz
·
4 hours ago
EssilorLuxottica Q3 2026 earnings beat estimates on wearables growth
Investing.com
·
4 hours ago
Earnings call transcript: EssilorLuxottica posts strong Q3 2026 growth as wearables gain
FashionNetwork USA
·
6 hours ago
EssilorLuxottica revenue boosted by traditional eyewear strength
Profile
EssilorLuxottica SA is a Franco-Italian vertically integrated multinational holding company registered in Charenton-Le-Pont and headquartered both in Paris and Milan. It designs, produces and markets ophthalmic lenses, equipment and instruments, prescription glasses and sunglasses. It was founded on 1 October 2018, and its name is an amalgamation of the two major corporations which merged to create it; the French Essilor and the Italian Luxottica. The two companies have, since the merger, been restructured as subsidiaries of the new entity.
Under the terms of the merger agreement, Essilor would purchase Luxottica, but Luxottica's leadership would be guaranteed prominent positions in the newly-formed corporation as well as some seats on its board of directors; the Luxottica founder, Leonardo Del Vecchio, was notably designated chairman. The first few years of EssilorLuxottica post-merger were marred by disputes over leadership roles, but Del Vecchio was able to bring them to a satisfactory end.
Essilor and Luxottica were respectively the world's leading manufacturers of ophthalmic lenses and of eyeglasses; upon the merger, EssilorLuxottica thus became a monopoly. Wikipedia
About EssilorLuxottica SA
CEOFrancesco Milleri
Employees214K
FoundedOct 1, 2018
Headquarters-
SectorMedical device
Websiteessilor.com
Awaiting results...
Call Time: Tue, Oct 20, 6:30 PM
Fiscal period
Q3 2026
- Normalized EPS / Est. (EUR)
- GAAP EPS / Est. (EUR)
- / -
Revenue / Est. (EUR)
- / 7.34B
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in EUR | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 7.23B | 7.23B | 7.41B | 7.41B |
Cost of goods sold | 3.08B | 3.08B | 2.77B | 2.77B |
Cost of revenue | 3.08B | 3.08B | 2.77B | 2.77B |
Research and development expenses | 169.00M | 169.00M | 166.50M | 166.50M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 3.26B | 3.26B | 3.33B | 3.33B |
Operating expense | 3.42B | 3.42B | 3.50B | 3.50B |
Total operating expenses | 6.50B | 6.50B | 6.27B | 6.27B |
Operating income | 737.50M | 737.50M | 1.14B | 1.14B |
Other non operating income | -9.50M | -9.50M | 5.00M | 5.00M |
EBT including unusual items | 639.50M | 639.50M | 1.09B | 1.09B |
EBT excluding unusual items | 688.00M | 688.00M | 1.08B | 1.08B |
Income tax expense | 144.50M | 144.50M | 271.00M | 271.00M |
Effective tax rate | 22.60% | 22.60% | 24.81% | 24.81% |
Other operating expenses | -9.00M | -9.00M | -1.00M | -1.00M |
Net income | 464.00M | 464.00M | 783.00M | 783.00M |
Net profit margin | 6.41% | 6.41% | 10.57% | 10.57% |
Earnings per share | - | - | - | - |
Interest and investment income | 25.00M | 25.00M | 19.50M | 19.50M |
Interest expense | -83.50M | -83.50M | -94.00M | -94.00M |
Net interest expenses | -58.50M | -58.50M | -74.50M | -74.50M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 1.26B | 1.26B | 1.67B | 1.67B |
Gain or loss from assets sale | 1.50M | 1.50M | -21.00M | -21.00M |